"The Covaxin has not yet had Phase 3 trials. Approval was premature and could be dangerous. @drharshvardhanshould please clarify. Its use s...

Drugs Controller General of India (DCGI), in a recent notification, said an investigator or researcher can undertake as many trials as appr...

The body says it may also collate its own list of combination drugs that are 'irrational' and 'unsafe' so that its members can avoid prescr...

The Centre is not influenced by actions previously taken by the Drug Controller General of India (DCGI), who had granted the approvals to t...

Pharmaceutical companies have long used India as a dumping ground for irrational fixed dose combination (FDC) drugs rejected by other count...

The companies have contended that the decision was taken by the government without issuing them a show cause notice or granting them a hear...

Abbott got a stay on five products in all, including codeine-based formulations and another for management of epilepsy.

P&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.

Corex is a combination of chlopheniramine maleate and codeine syrup - one of 344 drug combinations India banned over the weekend.

Andhra Pradesh (united) with nearly Rs 30,000 crore exports used to be in the second position after Maharashtra in terms of overall pharma ...

Companies which failed to report their safety status should do so within 3 weeks to retain their drug licences, the DGCI said.

The country's drug regulator has asked drug companies to submit the mandatory safety reports of their new drugs for every six months for th...

Industry and regulatory experts say the ban has come too late and in case of nimesulide, the prohibition will be ineffective.

The Drug Controller General Of India (DCGI) has issued showcause notices to Piramal Healthcare, Mankind Pharma and Morepen Laboratories for...

The government has mandated all human clinical trials being done in the country to be registered with the Indian Council of Medical Researc...

Slimona, Obitone and Riobant, the money-spinning drug that was launched just two years ago in India, allegedly causes suicidal tendencies i...

Considering the growth of the Indian pharma industry, the government has finally issued a notification for setting up a separate department...